Insurance status can influence an individual’s ability to access care, stated Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy.
Insured/uninsured status, region, and social determinants of health, such as lack of internet access, can all influence an individual’s ability to access care, stated Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy, who practices at Northwestern Medicine's Infectious Disease Center in Chicago.
Transcript
How can patients newly living with HIV access necessary care resources?
That depends on if they are insured or uninsured and the region that they're located in. So for an uninsured patient, there are a lot of free clinics oftentimes and they might be surprised by finding a free clinic in their area, if it’s maybe not a large city like Chicago. Obviously, we have many free clinics, clinics [that] are available free of cost.
Patients who have insurance can start by looking for a provider within their network; oftentimes, they can see who the provider is, if they're looking for a specific type of provider. So say if it's a transgender individual and they want a clinic specializing in transgender care, they can often look for that.
There are many resources available online to find care. And so it might just be that simple online search. And then we always want to think about, again, those social determinants of health. So somebody doesn't have the internet, what can they do? And so hopefully they could go to a free library or someplace like that where they would be able to then do that internet search to find those resources.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen